Axonics Snm System For Urinary Control; Indications; Precautions; Contraindications - Axonics 2501 Manuel

Axonics SNM System for Urinary Control

Indications

Axonics SNM Therapy for urinary control is indicated for
the treatment of urinary retention and the symptoms of
overactive bladder, including urinary urge incontinence
and significant symptoms of urgency-frequency alone or
in combination, in patients who have failed or could not
tolerate more conservative treatments.
Warning: This therapy is not intended for patients
with mechanical obstruction such as benign prostatic
hypertrophy, cancer, or urethral stricture.

Precautions

Clinician Training
■
Implanting clinicians should be trained on the
■
implantation and use of the Axonics SNM System.
Prescribing clinicians should be experienced in
■
the diagnosis and treatment of lower urinary tract
symptoms and should be trained on the use of the
Axonics SNM System.
6 6
Use in Specific Populations
■
The safety and effectiveness of this therapy has not
■
been established for:
Pregnant women
■
Pediatric use (patients under the age of 16)
■
Patients with neurological disease origins, such
■
as multiple sclerosis or diabetes
Bilateral stimulation
■

Contraindications

The Axonics SNM System is contraindicated for patients
who are unable to operate the Axonics SNM System.